The Article related to glucal triazole preparation pharmacokinetics mol docking antioxidant antisickling, antioxidant, glucal-based triazoles compounds, sickle cell disease, Carbohydrates: Glycosides and other aspects.Category: esters-buliding-blocks
On April 30, 2021, Vieira Veloso, Rodinei; Shamim, Anwar; Lamarrey, Yann; Stefani, Helio A.; Mozer Sciani, Juliana published an article.Category: esters-buliding-blocks The title of the article was Antioxidant and anti-sickling activity of glucal-based triazoles compounds – An in vitro and in silico study. And the article contained the following:
The sickle cell disease (SCD) has a genetic cause, characterized by a replacement of glutamic acid to valine in the β-chain of Hb. The disease has no effective treatment so far, and patients suffer a range from acute to chronic complications that include chronic hemolytic anemia, vaso-occlusive ischemia, pain, acute thoracic syndrome, cerebrovascular accident, nephropathy, osteonecrosis and reduced lifetime. The oxidation in certain regions of the Hb favors the reactive oxygen species (ROS) formation, which is the cause of many clin. manifestations. Antioxidants have been studied to reduce the Hb ROS levels, and in this sense, we have searched for new antioxidants glucal-based triazoles compounds with anti-sickling activity. Thirty analogs were synthesized and tested in in vitro antioxidant assays. Two of them were selected based in their effects and concentration-response activity and conducted to in cell assays. Both mols. did not cause any hemolysis and could reduce the red blood cell damage caused by hydrogen peroxide, in a model of oxidative stress induction that mimics the SCD. Moreover, one mol. I, besides reducing the hemolysis, was able to prevent the cell damage caused by the hydrogen peroxide. Later on, by in silico pharmacokinetics anal., we could see that I has appropriated properties for druggability and the probable mechanism of action is the binding to Peroxiredoxin-5, an antioxidant enzyme that reduces the hydrogen peroxide levels, verified after mol. docking assays. Thus, starting from 30 glucal-based triazoles mols. in a structure-activity relationship, we could select one with antioxidant properties that could act on RBC to reduce the oxidative stress, being useful for the treatment of SCD. The experimental process involved the reaction of (2R,3S,4R)-2-(Acetoxymethyl)-3,4-dihydro-2H-pyran-3,4-diyl diacetate(cas: 2873-29-2).Category: esters-buliding-blocks
The Article related to glucal triazole preparation pharmacokinetics mol docking antioxidant antisickling, antioxidant, glucal-based triazoles compounds, sickle cell disease, Carbohydrates: Glycosides and other aspects.Category: esters-buliding-blocks
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics